ULTIVA vs VANTRELA ER

Independent side-by-side comparison.

Rated against independent regulatory sources·Last updated August 22, 2026·How we rate

Possible drug interaction. ULTIVA and VANTRELA ER are different prescription medicines. Combining or switching between them can cause interactions — talk to a pharmacist or prescriber before making changes. This page is not medical advice.

Attribute	ULTIVA	VANTRELA ER
Rating	70/100	New
Pharmacy pays	—	~$239.83 /30
Type	RX	RX
Active ingredient	REMIFENTANIL HYDROCHLORIDE	HYDROCODONE BITARTRATE
Manufacturer	Mylan Institutional	Teva Branded Pharm
Dosage forms	Injectable	Tablet, extended release
Drug class	Opioid Agonist	Opioid Agonist
Boxed warning	Boxed warning	None
Half-life	—	about 3.8 hours (3.8 ± 0.3 hours)
Treats	Pain	Cough, Obstructive Lung Diseases, Postoperative Pain

ultiva vantrela er

Rating

70/100

New

Pharmacy pays

—

~$239.83 /30

Type

Active ingredient

REMIFENTANIL HYDROCHLORIDE

HYDROCODONE BITARTRATE

Manufacturer

Mylan Institutional

Teva Branded Pharm

Dosage forms

Injectable

Tablet, extended release

Drug class

Opioid Agonist

Boxed warning

None

Half-life

—

about 3.8 hours (3.8 ± 0.3 hours)

Treats

Pain

Cough, Obstructive Lung Diseases, Postoperative Pain

Frequently asked questions

What is the difference between Ultiva and Vantrela ER?

Ultiva contains Remifentanil Hydrochloride, while Vantrela ER contains Hydrocodone Bitartrate — they have different active ingredients.

Ratings are based on FDA regulatory (recall-safety) data. This comparison is for general reference only — not medical advice. Always consult a licensed professional before choosing or switching a medication.